Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia
Status:
RECRUITING
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
Evaluation of safety and efficacy of Nalbuphine versus Morphine patient controlled intravenous analgesia (PCIA) for the treatment of postoperative analgesia
Phase:
PHASE3
Details
Lead Sponsor:
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd